IP Library Patent Application 12205417
Patent Application
App. No. 12/205,417

Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/205,417
Abstract

The present invention provides for methods and kits for detecting sepsis, trauma/hemorrhage or inflammation in a subject. It is based, at least in part, on the discovery that Augmenter of Liver Regeneration (“ALR”) is an early marker of these conditions. Accordingly, in other embodiments, the present invention provides for a method of treating sepsis, traumatic/hemorrhagic shock and inflammation by inhibiting ALR.

Claims (9)

1 . A method of detecting sepsis in a subject, comprising measuring the level of Augmenter of Liver Regeneration in a sample collected from a subject to be tested for sepsis, and comparing the level to a baseline value, wherein an elevation in the level of Augmenter of Liver Regeneration relative to baseline is an indicator that the subject suffers from sepsis.

2 . The method of claim 1 , where the level of Augmenter of Liver Regeneration is measured by an enzyme-linked immunosorbent assay.

3 . A method of detecting inflammation in a subject, comprising measuring the level of Augmenter of Liver Regeneration in a sample collected from a subject to be tested for inflammation, and comparing the level to a baseline value, wherein an elevation in the level of Augmenter of Liver Regeneration relative to baseline is an indicator that the subject suffers from inflammation.

4 . The method of claim 3 , where the level of Augmenter of Liver Regeneration is measured by an enzyme-linked immunosorbent assay.

5 . A method of detecting traumatic/hemorrhagic shock in a subject, comprising measuring the level of Augmenter of Liver Regeneration in a sample collected from a subject to be tested for inflammation, and comparing the level to a baseline value, wherein an elevation in the level of Augmenter of Liver Regeneration relative to baseline is an indicator that the subject suffers from inflammation.

6 . The method of claim 5 , where the level of Augmenter of Liver Regeneration is measured by an enzyme-linked immunosorbent assay.

7 . A method of treating sepsis, comprising administering, to a subject suffering from sepsis, an effective amount of an inhibitor of Augmenter of Liver Regeneration.

8 . A method of treating inflammation, comprising administering, to a subject suffering from inflammation, an effective amount of an inhibitor of Augmenter of Liver Regeneration.

9 . A method of treating traumatic/hemorrhagic shock, comprising administering, to a subject suffering from inflammation, an effective amount of an inhibitor of Augmenter of Liver Regeneration.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 7, 2019
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (DEITR)
Reel/Frame 049989/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2009
From: GANDHI, CHANRASHEKHAR R.; VODOVOTZ, YORAM
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 022574/0718 →
CONFIRMATORY LICENSE Recorded Jan 15, 2009
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022113/0394 →